FIELD: chemistry.
SUBSTANCE: invention relates to novel spirocyclic cyclohexane derivatives of formula I: , where: R1 and R2 together form a ring and are -CH2CH2CH2-; R3 denotes a saturated, branched or straight, unsubstituted C1-5-alkyl; unsubstituted or monosubstituted with F, Cl, Br, I phenyl; 5-member heteroaryl containing sulphur as a heteroatom; unsubstituted or monosubstituted with F, Cl, Br, I phenyl, attached through a C1-3-alkyl group; R5 denotes H; R6 denotes H, F, Cl; R7, R8, R9 and R10 independently denote H, F, Cl, Br, I; X denotes O, NR17; R17 denotes H, COR12; R12 denotes H, unsaturated, branched or straight, unsubstituted or phenyl-substituted C1-5-alkyl; in form of a racemate; enantiomers, diastereomers, mixtures of enantiomers or diastereomers, or a separate enantiomer or diastereomer; bases and/or salts of physiologically compatible acids or cations.
EFFECT: compounds have binding action on the ORL1 receptor and the µ-opioid receptor, which enables their use to treat various diseases.
12 cl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
SPIROCYCLIC CYCLOHEXANE DERIVATIVES | 2008 |
|
RU2484092C2 |
HYDROXYMETHYL CYCLOHEXYLAMINES | 2009 |
|
RU2514192C2 |
SPIROCYCLIC AZAINDOLE DERIVATIVES | 2007 |
|
RU2468028C2 |
SPIRO(5,5)UNDECANE DERIVATIVES | 2009 |
|
RU2515895C2 |
SUBSTITUTED DERIVATIVES OF 4-AMINOCYCLOHEXANE | 2009 |
|
RU2525236C2 |
SPIROCYCLIC DERIVATIVES OF CYCLOHEXANE WITH AFFINITY TO ORL1 RECEPTOR | 2004 |
|
RU2383544C2 |
SUBSTITUTED CYCLOHEXYLDIAMINES | 2009 |
|
RU2526251C2 |
SUBSTITUTED DERIVATIVES OF 4-AMINOCYCLOHEXANE | 2009 |
|
RU2532545C2 |
SUBSTITUTED 4-AMINOCYCLOHEXANE DERIVATIVES | 2009 |
|
RU2503660C2 |
DERIVATIVES OF CIS-TETRAHYDRO-SPIRO(CYCLOHEXANE-1,1'-PYRIDO[3,4-b]INDOLE)-4-AMINE EFFECTIVE IN TREATING NEUROPATHIC AND/OR CHRONIC PAIN | 2011 |
|
RU2592283C2 |
Authors
Dates
2012-12-27—Published
2008-02-19—Filed